← Evidence map

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2025

Current status and trends of anti-tumor biosimilars in China from 2019 to 2023: A cross-sectional analysis.

Han Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41222808